MYC and cancer: These findings decipher a previously unsuspected mechanism involved in MYC(N) deregulation, and establish MYC family super-transcription factors as universal mediators in sustaining EZH2 oncogenic programs given that deregulation of MYC(N) occurs in >50% of human cancers.